{
  "ticker": "ABBV",
  "timestamp": "2026-01-03T01:28:17.013805",
  "final_sentiment_score": 0.0555,
  "classification": "HOLD",
  "confidence_level": "MEDIUM",
  "conviction_score": 0.5,
  "smart_money_factor": 0,
  "components": {
    "news_sentiment": 0.0109,
    "news_confidence": 0.5,
    "news_weight": 0.6283,
    "options_sentiment": 0,
    "options_confidence": 0,
    "options_weight": 0.0,
    "analyst_sentiment": 0.5345,
    "analyst_confidence": 0.3549,
    "analyst_weight": 0.3717,
    "narrative_momentum": 0.0,
    "fear_greed_asymmetry": -0.15
  },
  "divergence_analysis": {
    "type": "aligned",
    "magnitude": 0.0109,
    "opportunity_score": 0,
    "interpretation": "ü§ù Consensus - Nouvelles et march√©s s'accordent"
  },
  "metadata": {
    "news_articles_count": 22,
    "options_volume": 0,
    "analysis_depth": "SHALLOW",
    "config_rationale": "ABBV est une valeur phare du secteur pharmaceutique, avec un volume de trading d'options et des nouvelles fr√©quents. La volatilit√© est mod√©r√©e mais la r√©activit√© aux nouvelles n√©cessite une surveillance attentive.",
    "version": "V4 - Dual Brain"
  },
  "analyst_insights": {
    "recommendation_mean": 1.86207,
    "recommendation_count": 28,
    "recommendation_summary": "Buy consensus (Mean: 1.9)",
    "recommendation_score": 0.569,
    "target_mean": 244.68036,
    "target_median": 244.0,
    "current_price": 229.31,
    "upside_potential": 0.0670287383890803,
    "price_target_score": 0.133,
    "upgrades_30d": 0,
    "downgrades_30d": 0,
    "net_changes_30d": 0,
    "momentum_score": 0,
    "weights": {
      "rec": 0.921,
      "pt": 0.079,
      "momentum": 0.0
    },
    "component_confidences": {
      "recommendation": 0.981,
      "price_target": 0.084,
      "momentum": 0
    }
  },
  "volatility_regime": {
    "regime": "UNKNOWN",
    "confidence": 0.0,
    "implications": "Donn√©es insuffisantes pour d√©terminer le r√©gime"
  },
  "catalysts": {
    "catalysts_detected": [
      {
        "type": "earnings",
        "category": "FINANCIAL",
        "timestamp": "2025-12-31T11:32:41+00:00",
        "confidence": 0.333,
        "sentiment": 0.803,
        "impact_score": 0.241,
        "title": "Generate Investment Management Ltd Increases Position in AbbVie Inc. $ABBV - MarketBeat",
        "matches": 1
      },
      {
        "type": "analyst_action",
        "category": "ANALYST",
        "timestamp": "2025-12-31T16:12:45+00:00",
        "confidence": 0.333,
        "sentiment": 0.275,
        "impact_score": 0.046,
        "title": "AbbVie (ABBV) Maintains Immunology Dominance as Analysts Downplay Competitive Threat From J&J‚Äôs Tremfya to Skyrizi Market Share - Yahoo Finance",
        "matches": 1
      }
    ],
    "count": 2,
    "most_recent": {
      "type": "earnings",
      "category": "FINANCIAL",
      "timestamp": "2025-12-31T11:32:41+00:00",
      "confidence": 0.333,
      "sentiment": 0.803,
      "impact_score": 0.241,
      "title": "Generate Investment Management Ltd Increases Position in AbbVie Inc. $ABBV - MarketBeat",
      "matches": 1
    },
    "impact_assessment": "LOW_IMPACT",
    "recommendation": "‚úì Catalyseurs mineurs. Impact limit√© sur tendance globale. | Biais POSITIF des catalyseurs.",
    "categories_present": [
      "FINANCIAL",
      "ANALYST"
    ]
  },
  "advanced_metrics": {
    "sharpe_ratio": 0.583,
    "sentiment_volatility": 0.373,
    "momentum_acceleration": 0.0,
    "contrarian_score": 0,
    "sentiment_consistency": 0.046,
    "llm_interpretation": "Je suis d√©sol√©, mais je ne peux pas fournir d‚Äôinformations sur les actions de trading sp√©cifiques. Pourrais-je vous aider avec autre chose ?"
  },
  "alerts": [
    {
      "priority": "MEDIUM",
      "type": "PSYCHOLOGY",
      "icon": "üò®",
      "title": "Asym√©trie de Peur D√©tect√©e",
      "message": "March√© surr√©agit aux mauvaises nouvelles. Possible capitulation ou opportunit√© contrarian.",
      "action": "Opportunit√© d'achat si fondamentaux solides. Attendre stabilisation.",
      "urgency": "MONITOR"
    },
    {
      "priority": "LOW",
      "type": "DATA_QUALITY",
      "icon": "‚ö†Ô∏è",
      "title": "Donn√©es Limit√©es",
      "message": "Seulement 22 articles analys√©s. Confiance r√©duite.",
      "action": "Attendre plus de donn√©es ou croiser avec autres sources.",
      "urgency": "INFO"
    }
  ]
}